2Q'25 vs. 2Q'24 Results Sales: € 545.5 M (+4.9% vs. +3.8% BS(e) and +3.6% consensus); EBITDA: € 152.6 M (+7.2% vs. +3.7% BS(e) and +2.7% consensus); 1H'25 vs. 1H'24 Results Sales: € 986.6 M (+3.0% vs. +2.4% BS(e) and +2.4% consensus); EBITDA: € 243.6 M (+2.5% vs. +0.4% BS(e) and -0.2% consensus);
Rdos. 2T'25 vs 2T'24: Ventas: 545,5 M euros (+4,9% vs +3,8% BS(e) y +3,6% consenso); EBITDA: 152,6 M euros (+7,2% vs +3,7% BS(e) y +2,7% consenso). Rdos. 1S'25 vs 1S'24: Ventas: 986,6 M euros (+3,0% vs +2,4% BS(e) y +2,4% consenso); EBITDA: 243,6 M euros (+2,5% vs +0,4% BS(e) y -0,2% consenso).
NEWS SUMMARY: ARCELOR MITTAL, ELECTRICITY SECTOR, FLUIDRA, MELIA, MERLIN PROPERTIES, NEINOR HOMES, REDEIA, VISCOFAN. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 2Q’25 results to be released over the coming days in Spain. Growth resisting for now European stock markets ended with slight gains in view of the signs of resistance in the 2Q’25 GDP and ahead of the Fed meeting, w...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ARCELOR MITTAL, FLUIDRA, MELIA, MERLIN PROPERTIES, NEINOR HOMES, REDEIA, SECTOR ELÉCTRICO, VISCOFAN. EUROPA: AB INBEV, AIRBUS, BMW, ING GROEP, SANOFI, SAFRAN, SOCIETE GENERALE, VINCI. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 2T’25 que se publicarán en España y Europa en los próximos días. El crecimien...
AUCTUS PUBLICATIONS ________________________________________ New Zealand Energy (NZE CN)C; Target price of C$1.70 per share: Equity raise to progress Tariki gas storage – New Zealand Energy (NZE) has raised C$3 mm of new equity priced at C$0.18 per share. The proceeds of the raise will fund the desktop studies required to prepare the field development plan, derisking the gas storage project ahead of expected monetization within the next 12 months. It will also fund the repayment of the convertib...
Consensus expects ASML to grow revenues 2% next year, compared to 6-12% for its peers. That is conservative. If anything, we see room for ASML to outperform, driven by high leading-edge exposure. Beyond 2026, we also expect ASML to grow in the upper end of its peer group. Normal order intake in 3Q would allow management to ease concerns around 2026 growth, and with the stock trading on 25x forward earnings we see limited risk of further de-rating. We hence upgrade the stock to Buy, €790 Target...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.